Edgewise Therapeutics Inc (EWTX)
17.51
-0.40
(-2.23%)
USD |
NASDAQ |
Jun 14, 16:00
17.52
+0.01
(+0.06%)
After-Hours: 20:00
Edgewise Therapeutics Stock Buybacks (Quarterly): -239.15M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -239.15M |
| December 31, 2023 | -52.62M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.555M |
| September 30, 2022 | -129.72M |
| June 30, 2022 | |
| March 31, 2022 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.903M |
| March 31, 2021 | -187.05M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-239.15M
Minimum
Mar 2024
0.903M
Maximum
Jun 2021
-43.36M
Average
--
Median
Mar 2020
Stock Buybacks (Quarterly) Benchmarks
| Pfizer Inc | -- |
| Alnylam Pharmaceuticals Inc | -- |
| Catalyst Pharmaceuticals Inc | -140.70M |
| Cytokinetics Inc | -93.64M |
| Amicus Therapeutics Inc | 0.00 |